Yanina Grant-Huerta, Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA), sold 2,414 shares at $9.13 ($22K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Open-market sale of $22k ATRA by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRA | SELL | 2025-08-20 | $21K | — | Filing → |
| ATRA | SELL | 2025-05-20 | $15K | — | Filing → |